Relapse of COVID-19-associated mucormycosis in patients receiving posaconazole as maintenance treatment.

Autor: Salehi M; Research Center for Antibiotic Stewardship and Antimicrobial Resistance, Department of Infectious Diseases and Tropical Medicine, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran., Khodavaisy S; Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran ., Kamali Sarvestani H; Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran ., Sobati A; Department of Nursing and Midwifery, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran ., Pakdel F; Department of Oculo-Facial Plastic Surgery, Department of Ophthalmology, Farabi Hospital, Tehran University of Medical Sciences, Tehran, Iran., Samiee Fard E; Research Center for Antibiotic Stewardship and Antimicrobial Resistance, Department of Infectious Diseases and Tropical Medicine, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran., Darvishi M; Shefa Neuroscience Research Center, Khatam Alanbia Hospital, Tehran, Iran ., Shavandi M; Rajaie Cardiovascular Medical and Research Institute, Tehran, Iran., Mussini C; Department of Infectious Diseases and Tropical Medicine, University of Modena and Reggio Emilia, Modena, Italy., Rafat Z; Department of Medical Microbiology, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran., Ahmadikia K; Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran., Tabari A; Otorhinolaryngology Research Center, Imam Khomeini Hospital complex, Tehran University of Medical Sciences, Tehran, Iran.

Publikováno v: Journal of infection in developing countries [J Infect Dev Ctries] 2024 Sep 30; Vol. 18 (9.1), pp. S163-S169. Date of Electronic Publication: 2024 Sep 30.